chr3-179030965-T-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_022470.4(ZMAT3):āc.305A>Gā(p.Tyr102Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000109 in 1,613,562 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00011 ( 0 hom., cov: 32)
Exomes š: 0.00011 ( 2 hom. )
Consequence
ZMAT3
NM_022470.4 missense
NM_022470.4 missense
Scores
1
4
14
Clinical Significance
Conservation
PhyloP100: 3.82
Genes affected
ZMAT3 (HGNC:29983): (zinc finger matrin-type 3) This gene encodes a protein containing three zinc finger domains and a nuclear localization signal. The mRNA and the protein of this gene are upregulated by wildtype p53 and overexpression of this gene inhibits tumor cell growth, suggesting that this gene may have a role in the p53-dependent growth regulatory pathway. Alternative splicing of this gene results in two transcript variants encoding two isoforms differing in only one amino acid. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.13570085).
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZMAT3 | NM_022470.4 | c.305A>G | p.Tyr102Cys | missense_variant | 3/6 | ENST00000311417.7 | NP_071915.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZMAT3 | ENST00000311417.7 | c.305A>G | p.Tyr102Cys | missense_variant | 3/6 | 1 | NM_022470.4 | ENSP00000311221.2 | ||
ZMAT3 | ENST00000652290.1 | c.305A>G | p.Tyr102Cys | missense_variant | 3/10 | ENSP00000498847.1 | ||||
ZMAT3 | ENST00000432729.5 | c.305A>G | p.Tyr102Cys | missense_variant | 4/7 | 2 | ENSP00000396506.1 | |||
ZMAT3 | ENST00000414084.1 | c.305A>G | p.Tyr102Cys | missense_variant | 3/4 | 4 | ENSP00000398920.1 |
Frequencies
GnomAD3 genomes AF: 0.000112 AC: 17AN: 152194Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
17
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000140 AC: 35AN: 250872Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135604
GnomAD3 exomes
AF:
AC:
35
AN:
250872
Hom.:
AF XY:
AC XY:
17
AN XY:
135604
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000109 AC: 159AN: 1461368Hom.: 2 Cov.: 31 AF XY: 0.000118 AC XY: 86AN XY: 726984
GnomAD4 exome
AF:
AC:
159
AN:
1461368
Hom.:
Cov.:
31
AF XY:
AC XY:
86
AN XY:
726984
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000112 AC: 17AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000941 AC XY: 7AN XY: 74354
GnomAD4 genome
AF:
AC:
17
AN:
152194
Hom.:
Cov.:
32
AF XY:
AC XY:
7
AN XY:
74354
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
16
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 05, 2023 | The c.305A>G (p.Y102C) alteration is located in exon 3 (coding exon 2) of the ZMAT3 gene. This alteration results from a A to G substitution at nucleotide position 305, causing the tyrosine (Y) at amino acid position 102 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D;N
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Benign
T;T;.
Polyphen
B;B;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at